Literature DB >> 6214397

Mechanism of tumor and liver concentration of 111In and 169Yb: 111In and 169Yb binding substances in tumor tissues and liver.

A Ando, I Ando, T Hiraki, M Takeshita, K Hisada.   

Abstract

Tumor-bearing animals were injected with 111In- and 169Yb-citrate. Tumor homogenates, from which the nuclear fraction was removed, and the mitochondrial fractions of the host livers were digested with pronase P. After digestion, the supernatants of the reaction mixtures were applied to Sephadex G-100 columns. The resultant eluates were analyzed for radioactivity, protein, uronic acid, and sialic acids. Three peaks of radioactivity were obtained by gel filtration. The first peak, eluted in the void volume, contained a species whose molecular weight exceeded 40 000. The second peak consisted of substances with molecular weights of 9400-40 000. Radioactivity in the third peak was liberated 111In and 169Yb. These two nuclides in the second peak were bound to acid mucopolysaccharides and/or the sulfated carbohydrate chain of sulfated glycoprotein. It was thought that the nuclides in the first peak might be bound to some acid mucopolysaccharides. The second peak nuclides seemed to be bound to acid mucopolysaccharide that contained no uronic acids, and/or to the sulfated carbohydrate chain of sulfated glycoprotein. It was concluded that they were bound to the acid mucopolysaccharides and/or the sulfated carbohydrate chain of sulfated glycoprotein in tumor tissues and liver lysosomes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214397     DOI: 10.1007/bf00253424

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  10 in total

1.  Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids.

Authors:  D AMINOFF
Journal:  Biochem J       Date:  1961-11       Impact factor: 3.857

2.  Determination of pentose in the presence of large quantities of glucose.

Authors:  A H BROWN
Journal:  Arch Biochem       Date:  1946-10

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Comparison of viable and nonviable tumor uptake of Sc-46, Mn-54, Zn-65, In-111 and Au-195 with Ga-67 citrate in a hepatoma model.

Authors:  P L Hagan; D M Chauncey; S E Halpern; M L McKegney
Journal:  Eur J Nucl Med       Date:  1977-12-30

5.  Radiolanthanides as promising tumor scanning agents.

Authors:  K Hisada; A Ando
Journal:  J Nucl Med       Date:  1973-08       Impact factor: 10.057

6.  Tumor scanning with 67Ga citrate.

Authors:  C L Edwards; R L Hayes
Journal:  J Nucl Med       Date:  1969-02       Impact factor: 10.057

7.  Study of distribution of 169Yb, 67Ga and 111In in tumor tissue by macroautoradiography--comparison between viable tumor tissue and inflammatory infiltration around tumor.

Authors:  A Ando; K Doishita; I Ando; S Sanada; T Hiraki
Journal:  Radioisotopes       Date:  1977-06

8.  Subcellular distribution of 111In and 169Yb in tumor and liver.

Authors:  A Ando; I Ando; M Takeshita; T Hiraki; K Hisada
Journal:  Eur J Nucl Med       Date:  1981

9.  A comparative study on lysosomal accumulation of gallium-67 and indium-111 in Morris hepatoma 7316A.

Authors:  S Takeda; T Uchida; T Matsuzawa
Journal:  J Nucl Med       Date:  1977-08       Impact factor: 10.057

10.  On the mechanism of accumulation of 67Ga by tumors.

Authors:  L J Anghileri; M Heidbreder
Journal:  Oncology       Date:  1977       Impact factor: 2.935

  10 in total
  10 in total

1.  The influence of isotopic and nonisotopic carriers on the biodistribution and biokinetics of M3+-citrate complexes.

Authors:  K Schomäcker; W G Franke; E Henke; W D Fromm; G Maka; G J Beyer
Journal:  Eur J Nucl Med       Date:  1986

2.  67Ga-binding substances in stomach, small intestine, pancreas, and muscle.

Authors:  A Ando; I Ando; T Hiraki; K Hisada
Journal:  Eur J Nucl Med       Date:  1985

3.  67Ga accumulation in inflammatory lesion and its mechanism: comparison with malignant tumor.

Authors:  A Ando; K Nitta; I Ando; S Katsuda; N Tonami; T Hiraki; K Hisada; H Ogawa
Journal:  Eur J Nucl Med       Date:  1987

4.  67Ga-binding substances in abscess and normal tissues.

Authors:  A Ando; I Ando; T Hiraki; K Hisada; K Nitta; H Ogawa
Journal:  Eur J Nucl Med       Date:  1984

5.  Biodistributions of radioactive alkaline metals in tumor bearing animals: comparison with 201Tl.

Authors:  A Ando; I Ando; M Katayama; S Sanada; T Hiraki; H Mori; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1988

6.  Affinity of 167Tm-citrate for tumor and liver tissue.

Authors:  A Ando; I Ando; K Sakamoto; T Hiraki; K Hisada; M Takeshita
Journal:  Eur J Nucl Med       Date:  1983

7.  Tumor and liver uptake models of 67Ga-citrate.

Authors:  A Ando; I Ando; S Sanada; T Hiraki; K Hisada
Journal:  Eur J Nucl Med       Date:  1985

8.  Biodistributions of 201Tl in tumor bearing animals and inflammatory lesion induced animals.

Authors:  A Ando; I Ando; M Katayama; S Sanada; T Hiraki; H Mori; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1987

9.  Biodistributions of radioactive bipositive metal ions in tumor-bearing animals.

Authors:  A Ando; I Ando
Journal:  Biometals       Date:  1994-04       Impact factor: 2.949

10.  Tumour scanning with indium-111 dihaematoporphyrin ether.

Authors:  M R Quastel; A M Richter; J G Levy
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.